SOURCE: XTend Medical Corporation

September 09, 2008 09:38 ET

XTend Medical (XMDC) Signs Agreement With AmeriChoice, a Division of United Health Group, to Begin Remote Diabetic Patient Monitoring Program

SUN VALLEY, CA--(Marketwire - September 9, 2008) - XTend Medical Corporation (PINKSHEETS: XMDC), a company that delivers cutting-edge telemedicine solutions to the healthcare industry, announced today the company has signed an agreement to begin a Remote Diabetic Patient Monitoring Program with AmeriChoice, a division of United Health Group, the largest healthcare provider in the U.S.

"Through the hard work and perseverance of Mr. Jose Santoro of Medical Cost Management, and the management here at XTend Medical, we're proud to announce the company has an agreement in place to begin remotely monitoring diabetic patients with the largest managed care company here in the U.S. This agreement will deliver to AmeriChoice a comprehensive solution that will allow their diabetic patients to be remotely monitored and communicate results in order to effectively assist patients in managing their diabetes," stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby further states, "This clearly distances XTend Medical from our competition. With this agreement in place, XTend Medical is in a very advantageous position in the marketplace. We've worked hard to deliver the best cutting-edge telemedicine solutions to managed care companies, physicians, and patients and now the company is poised to break through and offer additional healthcare companies seeking the very best in remote monitoring programs for diabetics here in the U.S. and globally."

For any healthcare agency of physician group that would like to find more about the how XTend can assist in your management of diabetic patients, please visit the company website at or email us at

About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. XTend has developed a complete Remote Diabetic Patient Monitoring System that is currently being used by physicians and other healthcare agencies throughout the U.S. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information, please visit their website at

Safe Harbor

This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.

Contact Information